5162 Federal Register / Vol. 74, No. 18 / Thursday, January 29, 2009 / Notices 

Dr. Nyugen has entered into a 

Voluntary Settlement Agreement with 

ORI. As part of that Agreement, Dr. 

Nyugen admits to UCLA’s findings of 

fact but denies ORI’s findings that the 

actions rise to the level of scientific 

misconduct. The settlement is not an 

admission of liability on the part of the 

Respondent. Dr. Nyugen voluntarily 

agreed, for a period of three (3) years, 

beginning on December 29, 2008: 

(1) Not to serve in any advisory 

capacity to PHS, including but not 

limited to service on any PHS advisory 

committee, board, and/or peer review 

committee, or as a consultant; and 

(2) That although Respondent is not 

currently engaged in PHS–supported 

research, any institution that submits an 

application for PHS support for a 

research project on which the 

Respondent’s participation is proposed 

or that uses the Respondent in any 

capacity on PHS supported research, or 

that submits a report of PHS-funded 

research in which the Respondent is 

involved, must concurrently submit a 

plan for supervision of the Respondent(s 

duties to the funding agency for 

approval. The supervisory plan must be 

designed to ensure the scientific 

integrity of the Respondent(s research 

contribution. Respondent agreed to 

ensure that a copy of the supervisory 

plan also is submitted to ORI by the 

institution for ORI approval. 

Respondent agreed to not participate in 

any PHS-supported research until such 

a supervisory plan is submitted to ORI. 

FOR FURTHER INFORMATION CONTACT: 

Director, Division of Investigative 

Oversight, Office of Research Integrity, 

1101 Wootton Parkway, Suite 750, 

Rockville, MD 20852, (240) 453–8800. 

Chris B. Pascal, 

Director, Office of Research Integrity. 

[FR Doc. E9–1933 Filed 1–28–09; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Notice of Meeting: Secretary’s 

Advisory Committee on Genetics, 

Health, and Society 

Pursuant to Public Law 92–463, 

notice is hereby given of the eighteenth 

meeting of the Secretary’s Advisory 

Committee on Genetics, Health, and 

Society (SACGHS), U.S. Public Health 

Service. The meeting will be held from 

10 a.m. to approximately 5:30 p.m. on 

Thursday, March 12, 2009, and 8:30 

a.m. to approximately 3 p.m. on Friday, 

March 13, 2009, at the Hubert H. 

Humphrey Building, 200 Independence 

Avenue, SW., Washington, DC 20201. 

The meeting will be open to the public 

with attendance limited to space 

available. The meeting also will be Web 

cast. 

At this meeting, the Committee will 

begin to explore issues related to 

genetics and the future of the health 

care system with the first in a series of 

roundtables focusing on perspectives of 

stakeholders in the payer community. 

Other agenda items include a session on 

developments related to informed 

consent for genomic data sharing, 

discussion of the Committee’s next steps 

to address concerns related to 

consumer-initiated genomic services, 

and updates on Department of Health 

and Human Services and agency 

priorities. 

As always, the Committee welcomes 

hearing from anyone wishing to provide 

public comment on any issue related to 

genetics, health and society. Individuals 

who would like to provide public 

comment should notify the SACGHS 

Executive Secretary, Ms. Sarah Carr, by 

telephone at 301–496–9838 or e-mail at 

carrs@od.nih.gov. The SACGHS office is 

located at 6705 Rockledge Drive, Suite 

750, Bethesda, MD 20892. Anyone 

planning to attend the meeting, who is 

in need of special assistance, such as 

sign language interpretation or other 

reasonable accommodations, is also 

asked to contact the Executive 

Secretary. 

Under authority of 42 U.S.C. 217a, 

Section 222 of the Public Health Service 

Act, as amended, the Department of 

Health and Human Services established 

SACGHS to serve as a public forum for 

deliberations on the broad range of 

human health and societal issues raised 

by the development and use of genetic 

and genomic technologies and, as 

warranted, to provide advice on these 

issues. The draft meeting agenda and 

other information about SACGHS, 

including information about access to 

the Web cast, will be available at the 

following Web site: http:// 

oba.od.nih.gov/SACGHS/ 

sacghs_home.html. 

Dated: January 22, 2009. 

Jennifer Spaeth, 

Director, NIH Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–1867 Filed 1–28–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

intention of the Agency for Healthcare 

Research and Quality (AHRQ) to request 

that the Office of Management and 

Budget (OMB) approve the proposed 

information collection project: 

‘‘Assessing Organizational Responses to 

AHRQ’s Health Literacy Pharmacy 

Tools.’’ In accordance with the 

Paperwork Reduction Act of 1995, 44 

U.S.C. 3506(c)(2)(A), AHRQ invitesthe 

public to comment on this proposed 

information collection. 

DATES: Comments on this notice must be 

received by March 30, 2009. 

ADDRESSES: Written comments should 

be submitted to: Doris Lefkowitz, 

Reports clearance Officer, AHRQ, by email at doris.lefkowitz@ahrq.hhs.gov. 

Copies of the proposed collection 

plans, data collection instruments, and 

specific details on the estimated burden 

can be obtained from the AHRQ Reports 

Clearance Officer. 

FOR FURTHER INFORMATION CONTACT: 

Doris Lefkowitz, AHRQ Reports 

Clearance Officer, (301) 427–1477, or by 

e-mail at doris.leflowitz@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Proposed Project: Assessing 

Organizational Responses to AHRQ’s 

Health Literacy Pharmacy Tools 

According to the 2003 National 

Assessment of Adult Literacy, only 12 

percent of adults have proficient health 

literacy-the capacity to obtain, process, 

and understand basic health 

information and services needed to 

make appropriate health decisions. 

Limited health literacy often leads to 

medication errors. For example, one 

study found that a majority of adults 

with low health literacy did not 

understand instructions to ‘‘take 

medication on an empty stomach.’’ 

Overall, it is estimated that low health 

literacy costs the U.S. health care 

system $50 billion to $73 billion per 

year. Pharmacies can serve as an 

important source of medication 

information for people with limited 

health literacy, but relatively few 

pharmacies have implemented health 

literacy practices (Praska et al., 2005). 


rmajette on PRODPC74 with NOTICES
Federal Register / Vol. 74, No. 18 / Thursday, January 29, 2009 / Notices 5163 

Recognizing that pharmacies may 

need outside knowledge and assistance 

to improve their health literacy 

practices, AHRQ, through a previous 

task order, supported the creation of the 

following four health literacy tools for 

pharmacy settings, which have been 

validated in institutional pharmacy 

settings. 

1. Is Our Pharmacy Meeting Patients’ 

Needs? A Pharmacy Health Literacy 

Assessment Tool User’s Guide (Jacobson 

et al., 2007) 

2. Strategies to Improve 

Communication between Staff and 

Patients: Training Program for Pharmacy 

Staff (Kripalini & Jacobson, 2007). 

3. How to Create a Pill Card (Jacobson 

et al., 2008). 

4. Telephone Reminders: A Tool to 

Help Refill Medications on Time 

(Jacobson et al., 2008) 

AHRQ now proposes to distribute 

these tools to a more diverse set of 

pharmacies and to conduct in-depth 

case studies to enhance our 

understanding about the conditions that 

may facilitate or impede the adoption of 

the tools in these settings. AHRQ would 

use insights gained to develop materials 

(promotional implementation guides) 

that could assist interested pharmacies 

in putting the tools into practice and 

anticipating and overcoming obstacles 

to doing so. 

The pharmacy health literacy tools 

will be disseminated through an AHRQ 

Web site, which will also provide 

technical assistance to pharmacies that 

wish to implement the tools. A 

description of the tools and site will be 

distributed to pharmacists through 

national pharmacy organizations’ trade 

publications and a direct mailing to 

chain pharmacy headquarters. We 

anticipate that we would be able to 

reach as many as 60,000 individual 

pharmacists across the country through 

these channels. 

This project is being conducted 

pursuant to AHRQ’s statutory authority 

to conduct and support research on 

healthcare and on systems for the 

delivery of such care, including 

activities with respect to: The quality, 

effectiveness, efficiency, 

appropriateness and value of health care 

services; quality measurement and 

improvement; and health care costs, 

productivity, organization, and market 

forces. 42 U.S.C. 299a(a)(1), (2), and (6). 

Method of Collection 

Case Studies 

Through its contractor, AHRQ 

proposes to conduct 7 in-depth case 

studies to assess pharmacies’ 

experiences with implementation of one 

or more of these four health literacy 

tools, using interviews, site visits, 

review of documents and a survey of 

pharmacy staff from case study 

pharmacies. In addition, AHRQ will 

conduct 2 more limited studies of 

pharmacies that were aware of the tools 

but chose not to implement them. 

A 2-day site visit with be conducted 

with each of the 7 sites that implement 

at least one of the tools. Each site visit 

will include a walk-through of the 

pharmacy site to see the physical layout, 

an interview with the key informant or 

contact person, and individual 

interviews with up to eight additional 

pharmacy employees, including the 

pharmacy manager, staff pharmacists, 

pharmacy technicians, and pharmacy 

clerks. 

Therefore, up to 63 interviews will be 

completed across the 7 sites that 

implement one or more of the tools. In 

addition, up to 12 pharmacy staff at 

each of the 7 implementation sites will 

complete the tool’s Pharmacy Staff 

Survey contained in the Pharmacy 

Health Literacy Assessment Tool. 

For each of the two pharmacies which 

do not implement the tools, interviews 

will be conducted with up to 2 

informants per site. The content of this 

interview will be similar, but not 

identical, to the interviews with staff at 

the implementing sites. 

Web Site Visitors’ Survey 

For pharmacists and other visitors to 

the AHRQ Web site, we will conduct a 

voluntary survey regarding health 

literacy in general, and feedback 

regarding AHRQ’s health literacy tools. 

The Web site visitors’ survey will be 

available on-line. 

Estimated Annual Respondent Burden 

Exhibit I shows the estimated 

annualized burden hours for the 

respondents’ time to participate in this 

case study. The staff interview at the 

implementation sites will be completed 

with up to 9 pharmacy staff members 

from each of the 7 pharmacies that 

implement all or part of the health 

literacy tools. Staff interviews at the two 

nonimplementation sites will be 

completed with up to 2 individuals per 

pharmacy. The staff interviews are 

estimated to last 1 hour. The pharmacy 

staff survey will be completed by up to 

12 staff from the 7 implementation 

pharmacies and is estimated to take 

approximately 20 minutes. Lastly, the 

Web site visitor’s survey will be 

completed by about 150 respondents 

and is estimated to take up to 12 

minutes to complete. The total burden 

hours for all data collections is 

estimated to be 125 hours. 

Exhibit 2 shows the estimated 

annualized cost burden for the 

respondents’ time to provide the 

requested data. The estimated total cost 

burden is about $3,791. 

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS

Form Name Number of 

respondents 

Number of 

responses per 

respondent 

Hours per 

response 

Total burden 

hours 

Staff interview-implementing sites ................................................................... 7 9 1 63 

Staff interview-non-implementing sites ............................................................ 2 2 1 4 

Pharmacy staff survey ..................................................................................... 7 12 20/60 28 

Web site visitors survey ................................................................................... 150 1 12/60 30 

Total .......................................................................................................... 166 na na 125 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN

Form Name Number of 

respondents 

Total burden 

hours 

Average 

hourly wage 

rate* 

Total cost 

burden 

Staff interview-implementing sites ................................................................... 7 63 $30.33 $1,911 

Staff interview-non-implementing sites ............................................................ 2 4 30.33 121 

Pharmacy staff survey ..................................................................................... 7 28 30.33 849 


rmajette on PRODPC74 with NOTICES
5164 Federal Register / Vol. 74, No. 18 / Thursday, January 29, 2009 / Notices 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN—Continued 

Form Name Number of 

respondents 

Total burden 

hours 

Average 

hourly wage 

rate* 

Total cost 

burden 

Web site visitors survey ................................................................................... 150 30 30.33 910 

Total .......................................................................................................... 166 125 na 3,791

* The average hourly wage rate of $30.33 was calculated based on the following mean hourly wage rates: pharmacists—$47.58; pharmacy 

manager [medical & health services manager category]—$50.34; pharmacy tecimicians—$13.25; and pharmacy aides $10.15. The mean hourly 

wage rates for these occupations were obtained from the Bureau of Labor & Statistics on ‘‘Occupational Employment and Wages, May 2007,’’ 

found at: http//www.bls.gov/OES/current/oes291051.htm. 

Estimated Annual Costs to the 

Government 

The total cost of this contract to the 

government is $400,000. The project 

extends over three fiscal years. Exhibit 

3 shows a breakdown of the total cost 

as well as the annualized cost. 

EXHIBIT 3 

Cost component Total cost Annualized 

cost 

Project Development ............................................................................................................................................... $54,822 $18,274 

Data Collection Activities ......................................................................................................................................... 111,509 37,170 

Data Processing and Analysis ................................................................................................................................. 129,089 43,030 

Publication of Results .............................................................................................................................................. 63,736 21,245 

Project Management ................................................................................................................................................ 40,845 13,615 

Total .................................................................................................................................................................. 400,000 133,333 

Request for Comments 

In accordance with the above cited 

legislation, comments on the AHRQ 

information collection proposal are 

requested with regard to any of the 

following: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of functions 

of AHRQ, including whether the 

information will have practical utility; 

(b) the accuracy of AHRQ’s estimate of 

burden (including hours and costs) of 

the proposed collection of information; 

(c) ways to enhance the quality, utility, 

and clarity on the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the request for OMB 

approval of the proposed information 

collection. All comments will become a 

matter of public record. 

Dated: January 16, 2009. 

Carolyn M. Clancy, 

Director. 

[FR Doc. E9–1751 Filed 1–28–09; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Protection and Advocacy (P&A) 

Voting Access Application and Annual 

Report. 

OMB No.: 0970–0326. 

Description: This is a revision to 

include the application for the 

previously cleared Help America Vote 

Act (HAVA) Annual report. 

An application is required by Federal 

statute (the Help America Vote Act 

(HAVA) of 2002, Pub. L. 107–252, 

Section 291, Payments for Protection 

and Advocacy Systems, 42 U.S.C. 

15461). Each State Protection & 

Advocacy (P&A) System must prepare 

an application in accordance with the 

program announcement. 

There is no application kit; the P&As 

application may be in the format of its 

choice. It must, however, be signed by 

the P&As Executive Director or the 

designated representative, and contain 

the assurances as outlined under Part I. 

C. Use of Funds. The P&As designated 

representatives may signify their 

agreement with the conditions/ 

assurances by signing and returning the 

assurance document Attachment B, 

found in Part IV of this Instruction. The 

assurance document signed by the 

Executive Director of the P&A, or other 

designated person, should be submitted 

with the application to the 

Administration on Developmental 

Disabilities. 

An annual report is required by 

Federal statute (the Help America Vote 

Act (HAVA) of 2002, Pub. L. 107–252, 

Section 291, Payments for Protection 

and Advocacy Systems, 42 U.S.C. 

15461). Each State Protection & 

Advocacy (P&A) System must prepare 

and submit an annual report at the end 

of every fiscal year. The report 

addresses the activities conducted with 

the funds provided during the year. The 

information from the annual report will 

be aggregated into an annual profile of 

how HAVA funds have been spent. The 

report will also provide an overview of 

the P&A goals and accomplishments 

and permit the Administration on 

Developmental Disabilities to track 

progress to monitor grant activities. 

Respondents: Protection & Advocacy 

Systems—All States, the District of 

Columbia, Puerto Rico, the U.S. Virgin 

Islands, American Samoa, and Guam. 


rmajette on PRODPC74 with NOTICES